Related Experiment Videos
Laser in situ keratomileusis for myopic astigmatism
1Ophthalmology Department, Alexandria University, Egypt.
Purpose:
To evaluate the refractive results of laser in situ keratomileusis (LASIK) for myopic astigmatic eyes, and to assess the efficacy, accuracy, stability, and safety of the procedure.
Methods:
LASIK was performed on 113 eyes of 73 patients for correction of myopic astigmatism ranging from 1.00 to 5.00 D, as measured by manifest refraction, with a mean baseline refractive astigmatism of 2.09 +/- 1.12 D. The Chiron Automated Corneal Shaper was used to create a corneal flap, and laser ablation was performed using the Chiron-Technolas Keracor 116 excimer laser. Follow-up time was 12 months for all eyes.
Results:
Refractive astigmatism was stable by 3 months after surgery. At 1 year after LASIK, refractive astigmatism was reduced to a mean of 0.25 +/- 0.31 D (range 0 to 1.00 D). Sixty-one eyes (54%) had no residual astigmatism and 98 eyes (86.7%) had 0 to 0.50 D of refractive astigmatism. The mean percent reduction of preoperative astigmatism was 87.9 +/- 14.9%. The mean axis deviation of the surgically induced astigmatism was 2.1 +/- 3.1 degrees, with 96 eyes (84.9%) within 5 degrees of the desired axis. The percent correction of preoperative astigmatism in the proper axis was 97.1 +/- 15.5%. Spectacle-corrected visual acuity improved by 2 lines in 11 eyes (9.7%), and was reduced by 1 line only in 1 eye. There were no other significant complications.
Conclusion:
LASIK with the Chiron-Technolas Keracor 116 excimer laser was effective for correction of myopic astigmatism, with good stability after 3 months. The results were predictable with an acceptable degree of accuracy. LASIK is a safe procedure with very few complications.